Euclidean Capital LLC Portfolio Holdings

Euclidean Capital LLC

  • $735 Million
  • Q4 2024

Euclidean Capital LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $735 Million distributed in 11 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Spdr S&P 500 ETF Trust with a value of $525M, Ishares Msci India Index Fund with a value of $128M, Vanguard Ftse All World Ex Us with a value of $58.2M, Oric Pharmaceuticals, Inc. with a value of $7.98M, and Foghorn Therapeutics Inc. with a value of $7.43M.

Examining the 13F form we can see an decrease of $170M in the current position value, from $906M to 735M.

Euclidean Capital LLC is based out at New York, NY

Below you can find more details about Euclidean Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $735 Million
ETFs: $711 Million
Healthcare: $24.3 Million

Stock Holdings Table Market Cap. of $2 Billions to $10 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 11
  • Current Value $735 Million
  • Prior Value $906 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 0 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Euclidean Capital LLC Portfolio

Follow Euclidean Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Euclidean Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Euclidean Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email